Juvenile Dermatomyositis and Diffuse Cutaneous Systemic Sclerosis Overlap

Abstract

The overlapping nature of autoimmune diseases makes diagnosing and stratifying prognosis extremely difficult. Scleromyositis, the most common overlap syndrome, is typically seen in adults and is rarely seen in children. An overlap syndrome like scleromyositis would have clinical features of at least two connective tissue diseases (juvenile dermatomyositis and systemic sclerosis). Furthermore, the presence of anti-PM/Scl antibodies is critical. We describe a patient who presented with widespread skin tightening, hoarseness of voice, dysphagia, and muscle weakness that had been present for 6 months. The patient was diagnosed with overlap juvenile scleromyositis (scleroderma-dermatomyositis overlap). In practice, distinguishing this syndrome from dermatomyositis and scleroderma is critical.

Keywords

juvenile dermatomyositis - diffuse systemic sclerosis - scleroderma - Raynaud's phenomenon - connective tissue disease - overlap syndrome - scleromyositis - interstitial lung disease

• References

• 1 Jablonska S, Chorzelski TP, Blaszczyk M, Jarzabek-Chorzelska M, Kumar V, Beutner EH. Scleroderma/polymyositis overlap syndromes and their immunologic markers. Clin Dermatol 1992; 10 (04) 457-472
• 2 Christiphor-Stine L, Amato AA, Vleugels RA, Targoff IN, Shefner JM, Callen J, Curtis MR. Diagnosis and differential diagnosis of dermatomyositis and polymyositis in adults. UpToDate. https://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-dermatomyositis-and-polymyositis-in-adults# . Published February 24, 2022. Accessed August 9, 2022
• 3 Oldroyd A, Chinoy H. Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies. Curr Opin Rheumatol 2018; 30 (06) 606-613
• 4 D'Aoust J, Hudson M, Tatibouet S. et al; Canadian Scleroderma Research Group. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol 2014; 66 (06) 1608-1615
• 5 Wedderburn LR, McHugh NJ, Chinoy H. et al; Juvenile Dermatomyositis Research Group (JDRG). HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology (Oxford) 2007; 46 (12) 1786-1791
• 6 Ranque B, Bérezné A, Le-Guern V. et al. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010; 39 (06) 498-505
• 7 Fairley JL, Hansen D, Proudman S. et al; Australian Scleroderma Interest Group. Clinical features of systemic sclerosis-mixed connective tissue disease and systemic sclerosis overlap syndromes. Arthritis Care Res (Hoboken) 2021; 73 (05) 732-741
• 8 Bhansing KJ, Lammens M, Knaapen HK, van Riel PL, van Engelen BG, Vonk MC. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology. Arthritis Res Ther 2014; 16 (03) R111
• 9 Iaccarino L, Gatto M, Bettio S. et al. Overlap connective tissue disease syndromes. Autoimmun Rev 2013; 12 (03) 363-373
• 10 Fotis L, Baszis KW, White AJ, French AR. Four cases of anti-PM/SCL antibody-positive juvenile overlap syndrome with features of myositis and systemic sclerosis. J Rheumatol 2016; 43 (09) 1768-1769
• 11 Popescu NA, Manea D, Capitanescu G, Cinteza E, Ionescu MD, Balgradean M. Respiratory failure in a rare case of juvenile dermatomyositis: systemic scleroderma overlap syndrome. Maedica (Buchar) 2020; 15 (03) 394-400